The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the BPC 157 and TB 500: Unapproved and Regulated Patrick J Moloney posted on the topic LinkedIn BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Is BPC 157 Banned? Oral vs. Injectable Forms Explained